Pharmacogenetics in clinical practice: how far have we come and where are we going?
about
Comparison of delivery strategies for pharmacogenetic testing servicesCost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in GermanyPharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.Prerequisites to implementing a pharmacogenomics program in a large health-care systemPreemptive clinical pharmacogenetics implementation: current programs in five US medical centersOncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq studyPharmacogenetic Testing: Application in Mental Health Prescribing.Challenges of development and implementation of point of care pharmacogenetic testing.Disease-drug database for pharmacogenomic-based prescribing.High frequency of a single nucleotide substitution (c.-6-180T>G) of the canine MDR1/ABCB1 gene associated with phenobarbital-resistant idiopathic epilepsy in Border Collie dogs.Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.The challenges of implementing pharmacogenomic testing in the clinic.Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.Developing Pharmacogenomic Reports: Insights from Patients and Clinicians.The utility of pharmacogenetic testing to support the treatment of bipolar disorder.Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy.
P2860
Q26860925-4BDACC4B-7BDD-4625-B137-7B72FE4777A4Q28072203-6D81C4EB-0654-41D2-AE10-120C3A78A178Q33910107-DB1C3E55-4581-4BD4-8459-1866BA65D97DQ35635601-877CB6EF-241B-4086-9C9D-DF7120652558Q36166107-2639FD27-A56B-492A-9BF0-6A542CF9B384Q37168371-1D5A11A6-56DB-4059-BDF6-06C8A6C186CEQ38786972-E3B0CBF2-3B9F-42E0-8724-664A2952F00CQ39611892-419E84CB-C31C-4AD0-B0C9-1D3E385FD633Q39949691-F1D85A99-CCAF-416C-8770-CCFDDD31BB0FQ42154178-EB97372F-8453-4ADE-BC8F-9EC0766A58A8Q47592664-7B602B47-9E88-4464-A0B8-5DC3478CB023Q47929031-34697FB1-5EF9-4369-A63D-54047F3DC948Q50108150-0176F431-583B-459C-B839-198E805EEF89Q50117218-6E48E8F7-4E4B-4864-AFD2-74613EA0462EQ51733691-D5158094-7514-40B2-B315-14A83265B289Q55331535-ABF98735-118A-4E42-B858-3745978C46F4
P2860
Pharmacogenetics in clinical practice: how far have we come and where are we going?
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@ast
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@en
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@nl
type
label
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@ast
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@en
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@nl
prefLabel
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@ast
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@en
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@nl
P2860
P356
P1433
P1476
Pharmacogenetics in clinical practice: how far have we come and where are we going?
@en
P2093
Julie A Johnson
P2860
P304
P356
10.2217/PGS.13.52
P577
2013-05-01T00:00:00Z